explore -WSS

explore

author：leisure time 2025-09-30 15:17:10 - browse：2

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： With FDA staff opposed to Sarepta therapy, top official intervened

focus

leisure time

WSS

CDC concerned about possible undetected monkeypox spread in U.K.

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

As digital health tech proliferates, a new institute aims to cut through hype

Cloning humans is technically possible. It's curious no one has tried

Ask STAT: What do you want to know about ChatGPT in medicine?

The science behind Janet Jackson's pregnancy at 49

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Affirmative action in medical school literally saved lives

Sanders adds drug shortage policies to pandemic preparedness bill

How one medical school became remarkably diverse

Cloning humans is technically possible. It's curious no one has tried

Supreme Court strikes down use of affirmative action

Why hospitals are withdrawing from US News rankings

United colonoscopy coverage change 'may cost lives,' doctors say

How dance can help nurses traumatized by Covid

Apple is now the first public company to be valued at $3 trillion

Why drug prescriptions should include diagnoses

leisure time

At Orexo, a ‘turning point’ for everything but digital health

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Weight bias in eating disorder treatment complicated by new weight loss drugs

Group opposing PBM reform sets lobbying record

Why are elite athletes different? Take a look at their microbes

In early work, researchers turn to CRISPR to treat Alzheimer's

focus

knowledge

leisure time

focus